VEGFA and neoplasm: Representative viable and necrotic areas of immunostained sections from 231_WT tumors in Figure 4a and 231_VEGF tumors in Figure 4b show the decreased FN1 immunostaining in viable tumor regions of VEGF overexpressing tumors, but not in necrotic tumor regions.